127 results on '"Engert, Andreas"'
Search Results
2. Impact of the first COVID-19 lockdown in Germany on the rate of acute infections during intensive chemotherapy for Hodgkin lymphoma
3. Targeting CD30 in Patients with Hodgkin Lymphoma
4. Predictive value of baseline metabolic tumor volume in early-stage favorable Hodgkin Lymphoma – Data from the prospective, multicenter phase III HD16 trial
5. Targeting CD30 in Patients with Hodgkin Lymphoma
6. Personalized Medicine in Hodgkin Lymphoma?
7. Lymphocyte-Predominant Hodgkin Lymphoma
8. New Agents for Patients with Hodgkin Lymphoma
9. Treatment of Early Unfavorable HL
10. Nodular Lymphocyte-Predominant Hodgkin Lymphoma
11. Proton versus photon deep inspiration breath hold technique in patients with hodgkin lymphoma and mediastinal radiation: A Planning Comparison Of Deep Inspiration Breath Hold Intensity Modulation Radiotherapy And Intensity Modulated Proton Therapy
12. Novel radiotherapy techniques for involved-field and involved-node treatment of mediastinal Hodgkin lymphoma: When should they be considered and which questions remain open?
13. JAK inhibition with ruxolitinib in relapsed or refractory classical Hodgkin lymphoma: Final results of a phase II, open label, multicentre clinical trial (JeRiCHO).
14. Advances in the treatment of Hodgkin lymphoma
15. The Role of Autologous Transplantation in Hodgkin Lymphoma
16. Impact of bone marrow involvement on early positron emission tomography response and progression‐free survival in the HD18 trial for patients with advanced‐stage Hodgkin lymphoma.
17. Reinduction therapy with everolimus in combination with dexamethasone, high‐dose cytarabin and cisplatinum in patients with relapsed or refractory classical Hodgkin lymphoma: an experimental phase I/II multicentre trial of the German Hodgkin Study Group (GHSG HD‐R3i)
18. Involved Site Radiotherapy Extends Time to Premature Menopause in Infra-Diaphragmatic Female Hodgkin Lymphoma Patients – An Analysis of GHSG HD14- and HD17-Patients.
19. Reduced-Intensity Chemotherapy in Patients With Advanced-Stage Hodgkin Lymphoma
20. Volumetric assessment of mediastinal lymphoma masses in Hodgkin lymphoma.
21. Treatment of Early Favorable Hodgkin Lymphoma
22. Doxorubicin, vinblastine, dacarbazine and lenalidomide for older Hodgkin lymphoma patients: final results of a German Hodgkin Study Group (GHSG) phase‐I trial.
23. Prospective study of brentuximab vedotin in relapsed/refractory Hodgkin lymphoma patients who are not suitable for stem cell transplant or multi‐agent chemotherapy.
24. Hodgkin Lymphoma-Derived Extracellular Vesicles Change the Secretome of Fibroblasts Toward a CAF Phenotype.
25. Leucocyte and eosinophil counts predict progression‐free survival in relapsed or refractory classical Hodgkin Lymphoma patients treated with PD1 inhibition.
26. Checkpoint Inhibition in Hodgkin Lymphoma - a Review.
27. Current and future immunotherapeutic approaches in Hodgkin lymphoma.
28. Evidence of Inbreeding in Hodgkin Lymphoma.
29. Early thymus and activation-regulated chemokine (TARC) reduction and response following panobinostat treatment in patients with relapsed/refractory Hodgkin lymphoma following autologous stem cell transplant.
30. Phase IA/ II, multicentre, open-label study of the CD40 antagonistic monoclonal antibody lucatumumab in adult patients with advanced non- Hodgkin or Hodgkin lymphoma.
31. Brentuximab vedotin (SGN-35) in patients with transplant-naive relapsed/refractory Hodgkin lymphoma.
32. Interleukin-10 Gene Polymorphisms are Associated With Freedom From Treatment Failure for Patients With Hodgkin Lymphoma.
33. Adolescents with Hodgkin lymphoma: old children or young adults?
34. The Role of Autologous Transplantation in Hodgkin Lymphoma.
35. Meta-Analyses of Early-Stage Hodgkin Lymphoma.
36. Elevated pretreatment interleukin-10 serum level is an International Prognostic Score (IPS)-independent risk factor for early treatment failure in advanced stage Hodgkin lymphoma.
37. Lenalidomide in patients with refractory or multiple relapsed Hodgkin lymphoma.
38. Second Malignancy Risk After Treatment of Hodgkin Lymphoma
39. Gonadal Dysfunction and Fertility Preservation in Hodgkin Lymphoma Patients
40. Cancer-Related Fatigue in Hodgkin Lymphoma
41. Quality of Life in Hodgkin Lymphoma
42. Other New Agents for Hodgkin Lymphoma
43. Cardiovascular and Pulmonary Late Effects
44. What Have We Learnt from Genomics and Transcriptomics in Classic Hodgkin Lymphoma
45. Allogeneic Transplantation for Relapsed Hodgkin Lymphoma
46. The Management of HIV-Hodgkin Lymphoma
47. The Management of Hodgkin Lymphoma During Pregnancy
48. Relapsed and Refractory Hodgkin Lymphoma
49. The Management of Older Patients with Hodgkin Lymphoma
50. Principles of Radiation Therapy for Hodgkin Lymphoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.